Argos Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.45M Buy
1,207
+118
+11% +$121K 0.38% 34
2026
Q1
$1M Buy
1,089
+62
+6% +$62.9K 0.29% 41
2025
Q4
$1.1M Buy
+1,027
New +$982K 0.3% 36

Other funds holding LLY

Argos Wealth Advisors's LLY Position: Q2 2026 in Review

Argos Wealth Advisors increased its Eli Lilly (LLY) stake by 11% in Q2 2026, buying an estimated $121K and bringing the position to 1,207 shares worth $1.45M. The position accounts for 0.38% of the portfolio, ranked #34.

Argos Wealth Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Argos Wealth Advisors held 1,207 shares of Eli Lilly worth $1.45M as of Q2 2026.
  • Argos Wealth Advisors bought 118 Eli Lilly shares in Q2 2026, an estimated $121K.
  • Eli Lilly made up 0.38% of Argos Wealth Advisors's portfolio in Q2 2026, its #34 holding.
  • Argos Wealth Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Argos Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.